BlackRock, Inc.

13F Holdings History for SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Symbol: SLNO on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 2.77M shares
Security Ownership: 5.5%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in SOLENO THERAPEUTICS INC Common Stock, $0.001 par value per share (SLNO)

2025-07-17 - BlackRock, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.77M shares of SOLENO THERAPEUTICS INC Common Stock, $0.001 par value per share (SLNO). This represents 5.5% percent ownership of the company. In their previous filing dated 2025-02-05, BlackRock, Inc. had reported owning 2.01M shares, indicating an increase of 37.6% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BlackRock, Inc.	5.5%	+16%	$211M	2.77M	+756,435	+37.6%	$76.26	13G	6/30/2025	17 Jul 2025 20:12:45
BlackRock, Inc.	4.7%		$127M	2.01M			$63.27	13G/A	12/31/2024	5 Feb 2025 17:28:50

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	+0%	$236M	3.49M	+647,505	+22.8%	$67.60	Q3 2025
6/30/2025	0%	+0%	$238M	2.84M	+931,421	+48.7%	$83.78	Q2 2025
3/31/2025	0%	0%	$137M	1.91M	-96,464		$71.45	Q1 2025
12/31/2024	0%	0%	$90.3M	2.01M	-2,027	-0.1%	$44.95	Q4 2024
9/30/2024	0%		$102M	2.01M			$50.49	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.